Interpace Biosciences (NASDAQ:IDXG) Upgraded by Zacks Investment Research to Hold

Interpace Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Interpace Biosciences Upgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Strong Sell.

View More Interpace Biosciences (NASDAQ:IDXG) Upgraded by Zacks Investment Research to Hold